How much did Kasvu Therapeutics raise?

Kasvu Therapeutics raised $34M at Series A, announced 24 September 2026.

Who founded Kasvu Therapeutics?

Jami Mandelin is CEO & Co-Founder of Kasvu Therapeutics.

What does Kasvu Therapeutics do?

Kasvu Therapeutics operates in HealthTech and is based in Finland.

FundedStartupsDaily / HealthTech / Kasvu Therapeutics

Kasvu Therapeutics raises $34M

Kasvu Therapeutics announced a Series A round of $34M on 24 September 2026. The company operates in HealthTech and is based in Finland. It was founded by Jami Mandelin, CEO & Co-Founder. Announced yesterday.

Raised

$34M

Stage

Series A

Industry

HealthTech

Country

Finland

Founder

Jami Mandelin

CEO & Co-Founder, Kasvu Therapeutics

LinkedIn profile kasvutx.com

Outreach angles

-Jami Mandelin serves as CEO and co-founder of Kasvu Therapeutics, which spun out of University of Helsinki research.
-The company was founded on Professor Eero Castren's research into BDNF and TrkB signaling mechanisms in the brain.
-The Series A will fund preclinical studies and take KTX-0141, a non-hallucinogenic depression candidate, into Phase 1/1b human trials in late 2027.